Physician profile
Edward S Shoemaker
NPI 1437153400
$5,760.80
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.53 · 2020: $156 · 2021: $5,443 · 2022: $137.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,271.71 | 2021 | |
| Abbvie INC. | $213.91 | 2020-2022 | |
| Medtronic USA, INC. | $88.41 | 2020 | |
| Integra Lifesciences Corporation | $40.75 | 2021 | |
| Boston Scientific Corporation | $29.63 | 2021 | |
| Intuitive Surgical, INC. | $26.47 | 2022 | |
| Baxter Healthcare | $24.53 | 2019 | |
| Mayne Pharma Commercial LLC | $19.60 | 2022 | |
| Axonics, INC. | $16.12 | 2022 | |
| Organon LLC | $15.83 | 2022 | |
| Ibsa Pharma INC. | $13.84 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Shoemaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.